NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against TFI International Inc. (“TFI” or “the Company”) (NYSE: TFII) and certain of its officers.

image for news TFII INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that TFI International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Canopy Growth Corporation (“Canopy” or “the Company”) (NASDAQ: CGC) and certain of its officers.

image for news CGC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Canopy Growth Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against SoundHound AI, Inc. (“SoundHound” or “the Company”) (NASDAQ: SOUN) and certain of its officers.

image for news SOUN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that SoundHound AI, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Sana Biotechnology, Inc. (“Sana” or “the Company”) (NASDAQ: SANA) and certain of its officers.

image for news SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

PRINCETON, N.J.--(BUSINESS WIRE)--UroGen Pharma Ltd. (Nasdaq: URGN), a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights a duration of response of nearly four years from a long-term follow-up study with JELMYTO® (mitomycin) for pyelocalyceal solution, which is FDA-approved for the treatment of low-grade upper tract urothelial cancer (LG-UTUC) in adult patients. Among patients from the OLYMPUS trial who achie.

image for news OLYMPUS Long-Term Follow-Up Study Reports Nearly Four-Year Duration of Response in Subset of Patients with Low-Grade Upper Tract Urothelial Cancer Who Achieved a Complete Response to Initial JELMYTO Treatment

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Everus Construction Group, Inc. (“Everus” or “the Company”) (NYSE: ECG) and certain of its officers.

image for news ECG INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Everus Construction Group, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

The April bar could form a strong monthly reversal, adding to the evidence that the 4835 bottom is significant. However, there are various paths the recovery could take.

image for news S&P 500: The Recovery Faces A Key Test - Week Starting 28th April (Technical Analysis)

NEW YORK , April 27, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against BigBear.ai Holdings, Inc. ("BigBear" or "the Company") (NYSE: BBAI) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired BigBear securities between March 31, 2022 and March 25, 2025, both dates inclusive (the "Class Period").

image for news BBAI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BigBear.ai Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

MP Materials: An Unusual Momentum Play — Positive

MP   Seeking Alpha — April 27, 2025

Average trading volume for the past 10 days vs the past 3 months is up by over 140%. MP Materials is America's best chance to regain control over the rare earth elements supply chain, especially after the trade tensions between China and the US have recently escalated. The chart looks compelling, showing a clear turnaround since August 2024. The RSI is in the 50s (very attractive as well).

image for news MP Materials: An Unusual Momentum Play

NLR: Nuclear Stocks Snap Back, But The Damage Has Been Done — Negative

NLR   Seeking Alpha — April 27, 2025

Amid global equity volatility in 2025, NLR has shown slight alpha compared to the S&P 500, but its technicals and valuation suggest a hold rating. NLR's assets under management surged to $1 billion, but its high expense ratio and low dividend yield are concerning factors. The ETF's portfolio is concentrated in small-cap growth stocks, with a significant international exposure that benefits from a weaker dollar.

image for news NLR: Nuclear Stocks Snap Back, But The Damage Has Been Done

Heavy is the head that wears the crown. Alphabet (GOOGL 1.70%) (GOOG 1.52%), the parent of Google, and Meta Platforms (META 2.65%), formerly known as Facebook, are facing antitrust litigation regarding the ways they have maintained their dominance in internet search and social media.

image for news 2 Magnificent AI Stocks Down 27% and 32% That Investors Will Wish They Bought on the Dip

About 300 London-based staff of Google DeepMind have been seeking to join the Communication Workers Union in recent weeks, the report said, citing people familiar with the matter.

image for news DeepMind UK staff to unionize and challenge deals with Israel links, FT reports

Emcor Group: Long-Term Beneficiary Of AI Growth — Positive

EME   Seeking Alpha — April 27, 2025

EMCOR Group (EME) is a strong investment due to margin expansion, a robust balance sheet, and record RPOs in the data center sector. EME's diverse operations include electrical/mechanical construction and facility services, with 97% of revenue from the U.S. and 3% from the U.K. Key growth drivers include the increasing demand for AI data centers and natural gas power plants, supported by a vigorous acquisition strategy.

image for news Emcor Group: Long-Term Beneficiary Of AI Growth

1 Warren Buffett Stock That Turned $1,000 Into $225,000 — Positive

KO   The Motley Fool — April 27, 2025

They don't call him "the Oracle of Omaha" for nothing. Thanks to a phenomenal track record running Berkshire Hathaway , Warren Buffett is an investing legend.

image for news 1 Warren Buffett Stock That Turned $1,000 Into $225,000

Market uncertainty is high right now thanks to economic and geopolitical issues. Since the start of the year the S&P 500 index (^GSPC 0.74%) has fallen around 8% or so, but it had fallen by around 15% at one point.

image for news Why This High-Yield Dividend King Has Plunged 25% and Why You Should Buy It Now

NEW YORK, April 27, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of e.l.f. Beauty, Inc. (“Elf”) (NYSE: ELF) between November 1, 2023 and November 19, 2024, both dates inclusive (the “Class Period”), of the important May 5, 2025 lead plaintiff deadline.

image for news ELF DEADLINE NOTICE: ROSEN, A LONGSTANDING LAW FIRM, Encourages e.l.f. Beauty, Inc. Investors to Secure Counsel Before Important May 5 Deadline in Securities Class Action – ELF

Warren Buffett has always strongly believed in two things: the strength of American companies and the benefits of long-term investing. And if you put these elements together, you can construct an investing strategy that's likely to score a win.

image for news This Warren Buffett-Approved Vanguard Fund Could Turn $300 Per Month Into $1 Million

Energy Transfer 's (ET -0.88%) business prints cash. The midstream giant's diversified portfolio of pipelines, processing plants, storage terminals, and export facilities acts as a toll booth for the country's energy superhighway.

image for news This 7.5%-Yielding Dividend Stock Is a Super Investment for Making Passive Income

Should You Buy Palantir Before May 5? — Neutral

PLTR   The Motley Fool — April 27, 2025

Palantir Technologies (PLTR 4.63%) has soared in recent years -- and even defied today's market turmoil. Though the stock slipped along with major indexes in recent weeks, it's since rebounded and is up 33% so far this year.

image for news Should You Buy Palantir Before May 5?

BlueLinx Holdings: Strong Execution, More Clarity Incoming — Positive

BXC   Seeking Alpha — April 27, 2025

BlueLinx Holdings is an intermediary in the building materials space, leveraging a vast warehouse network to serve construction projects across the United States. The business is cyclical, influenced by housing market conditions and interest rates, with current high rates impacting remodeling and home starts. Despite recent revenue and profit declines, BlueLinx trades at an attractive multiple and has strong growth potential once interest rates fall.

image for news BlueLinx Holdings: Strong Execution, More Clarity Incoming